Harry Keyserling

8.4k total citations · 2 hit papers
87 papers, 5.6k citations indexed

About

Harry Keyserling is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Harry Keyserling has authored 87 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Epidemiology, 27 papers in Infectious Diseases and 25 papers in Immunology. Recurrent topics in Harry Keyserling's work include Respiratory viral infections research (22 papers), Pneumonia and Respiratory Infections (20 papers) and Influenza Virus Research Studies (15 papers). Harry Keyserling is often cited by papers focused on Respiratory viral infections research (22 papers), Pneumonia and Respiratory Infections (20 papers) and Influenza Virus Research Studies (15 papers). Harry Keyserling collaborates with scholars based in United States, Canada and United Kingdom. Harry Keyserling's co-authors include Myron J. Levin, Lorry G. Rubin, Per Ljungman, Athos Bousvaros, E. Graham Davies, Marcie Tomblyn, Shireesha Dhanireddy, Insoo Kang, Lillian Sung and Robin K. Avery and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and PEDIATRICS.

In The Last Decade

Harry Keyserling

87 papers receiving 5.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

2013 1.1k citations Myron J. Levin, Harry Keyserling et al. Clinical Infectious Diseases profile →
Executive Summary: 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

2014 649 citations Myron J. Levin, Harry Keyserling et al. Clinical Infectious Diseases profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Harry Keyserling	3.4k	1.7k	965	685	520	87	5.6k
Anton M. van Loon	4.9k 1.4×	2.9k 1.7×	713 0.7×	477 0.7×	481 0.9×	184	7.7k
Lorry G. Rubin	2.0k 0.6×	1.5k 0.8×	505 0.5×	347 0.5×	780 1.5×	90	4.5k
Timo Vesikari	2.8k 0.8×	2.0k 1.2×	526 0.5×	694 1.0×	243 0.5×	120	5.8k
J. Anthony G. Scott	4.2k 1.2×	1.2k 0.7×	480 0.5×	1.1k 1.6×	1.2k 2.3×	160	7.5k
Adriana Weinberg	4.3k 1.3×	1.2k 0.7×	1.5k 1.6×	297 0.4×	265 0.5×	234	6.3k
David W. Scheifele	4.0k 1.2×	1.1k 0.7×	569 0.6×	2.1k 3.1×	444 0.9×	239	5.6k
Edward N. Janoff	4.5k 1.3×	2.9k 1.7×	1.5k 1.5×	826 1.2×	644 1.2×	146	7.9k
Tumani Corrah	2.9k 0.9×	3.4k 1.9×	1.6k 1.7×	428 0.6×	759 1.5×	110	6.6k
Flor M. Muñoz	3.8k 1.1×	1.7k 1.0×	672 0.7×	1.2k 1.8×	614 1.2×	205	6.8k
Tomàs Pumarola	2.5k 0.7×	2.2k 1.3×	463 0.5×	301 0.4×	475 0.9×	293	5.0k

Countries citing papers authored by Harry Keyserling

Since Specialization

Citations

This map shows the geographic impact of Harry Keyserling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Keyserling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Keyserling more than expected).

Fields of papers citing papers by Harry Keyserling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry Keyserling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Keyserling. The network helps show where Harry Keyserling may publish in the future.

Co-authorship network of co-authors of Harry Keyserling

This figure shows the co-authorship network connecting the top 25 collaborators of Harry Keyserling. A scholar is included among the top collaborators of Harry Keyserling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry Keyserling. Harry Keyserling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Halasa, Natasha, Michael A. Gerber, Andrea A. Berry, et al.. (2014). Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age. Journal of the Pediatric Infectious Diseases Society. 4(3). 214–224. 23 indexed citations

Wright, Jennifer G., Brian D. Plikaytis, Charles E. Rose, et al.. (2013). Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: A randomized trial. Vaccine. 32(8). 1019–1028. 29 indexed citations

Pan, Yi, Charles E. Rose, Michael Haber, et al.. (2013). Assessing Agreement of Repeated Binary Measurements with an Application to the CDC’s Anthrax Vaccine Clinical Trial. The International Journal of Biostatistics. 9(1). 19–32. 6 indexed citations

Schutze, Gordon E., Rodney E. Willoughby, Michael T. Brady, et al.. (2013). Clostridium difficile Infection in Infants and Children. PEDIATRICS. 131(1). 196–200. 191 indexed citations

Edupuganti, Srilatha, Harry Keyserling, Rama Akondy, et al.. (2012). A Randomized, Double-Blind, Controlled Trial of the 17D Yellow Fever Virus Vaccine Given in Combination with Immune Globulin or Placebo: Comparative Viremia and Immunogenicity. American Journal of Tropical Medicine and Hygiene. 88(1). 172–177. 16 indexed citations

Stewart, Brock, Charles E. Rose, Jerome I. Tokars, et al.. (2012). Health-related quality of life in the CDC Anthrax Vaccine Adsorbed Human Clinical Trial. Vaccine. 30(40). 5875–5879. 3 indexed citations

Belshe, Robert B., Sharon E. Frey, Irene Graham, et al.. (2011). Safety and Immunogenicity of Influenza A H5 Subunit Vaccines: Effect of Vaccine Schedule and Antigenic Variant. The Journal of Infectious Diseases. 203(5). 666–673. 50 indexed citations

Akondy, Rama, Joseph D. Miller, Srilatha Edupuganti, et al.. (2009). The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response. The Journal of Immunology. 183(12). 7919–7930. 239 indexed citations

Keyserling, Harry. (2006). Immunogenicity of a Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine Against Serogroups A, C, Y, and W-135 (MCV-4) in 9 to 15-Month Olds. 4 indexed citations

10.

Gorse, Geoffrey J., W Keitel, Harry Keyserling, et al.. (2006). Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: A randomized, double-blinded, controlled, multicenter trial. Vaccine. 24(33-34). 5950–5959. 83 indexed citations

11.

Keyserling, Harry. (2004). Augmentation of the Immune Response to a Quadrivalent Meningococcal (A,C,Y,W-135) Diphtheria Conjugate Vaccine (MCV-4) by Co-administration with Tetanus-diphtheria Vaccine (Td) in Healthy Adolescents. 3 indexed citations

12.

Kim, Myong‐Jin, Anne N. Nafziger, Clayton Harro, et al.. (2003). Revaccination of healthy nonresponders with hepatitis B vaccine and prediction of seroprotection response. Vaccine. 21(11-12). 1174–1179. 42 indexed citations

13.

Tripp, Ralph A., Deborah Moore, Albert E. Barskey, et al.. (2002). Peripheral Blood Mononuclear Cells from Infants Hospitalized Because of Respiratory Syncytial Virus Infection Express T Helper–1 and T Helper–2 Cytokines and CC Chemokine Messenger RNA. The Journal of Infectious Diseases. 185(10). 1388–1394. 67 indexed citations

14.

Rennels, Margaret B., Kathryn M. Edwards, Harry Keyserling, et al.. (2001). Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants. The Pediatric Infectious Disease Journal. 20(2). 153–159. 45 indexed citations

15.

Levine, Gail L., et al.. (2001). Infection control programs at children’s hospitals: A description of structures and processes. American Journal of Infection Control. 29(3). 145–151. 20 indexed citations

16.

Sinkowitz, Ronda L., et al.. (1997). Epidemiology of vancomycin usage at a children's hospital, 1993 through 1995. The Pediatric Infectious Disease Journal. 16(5). 485–489. 31 indexed citations

17.

Bresee, Joseph, Marc Fischer, Scott F. Dowell, et al.. (1996). Vitamin A therapy for children with respiratory syncytial virus infection: a multicenter trial in the United States. The Pediatric Infectious Disease Journal. 15(9). 777–782. 65 indexed citations

18.

Hymes, Leonard C., et al.. (1996). Bacteremia in a pediatric hemodialysis unit secondary toEnterococcus fecalis. Pediatric Nephrology. 10(1). 55–57. 5 indexed citations

19.

Abzug, Mark J., et al.. (1995). Neonatal Enterovirus Infection: Virology, Serology, and Effects of Intravenous Immune Globulin. Clinical Infectious Diseases. 20(5). 1201–1206. 153 indexed citations

20.

Torfason, Einar G., et al.. (1992). Immunoglobulin class and subclass-specific monoclonal antibody sandwich ELISA for the detection of antibodies against coxsackieviruses B, types 1–5. Journal of Virological Methods. 37(3). 289–303. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact